NAGE vs TROW · P/E 59, rev $61.3M vs P/E 12, rev $3.76B
Niagen Bioscience, Inc. (NAGE) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the NAGE and TROW stock pages for the full models.
Not investment advice.